Improving outcomes for cancer patients
Learn how we improve patient outcomes through radiation oncology.
News
Principal Investigator Interview: RTOG 3521 Study of Combination Toripalimab and Chemotherapy in Recurrent Metastatic Nasopharyngeal Cancer
Read morePrincipal Investigator Interview: The ‘KEYSTROKE’ RTOG 3507 Study of Pembrolizumab plus Stereotactic Re-Irradiation for Recurrent Head and Neck Cancer
Read morePrincipal Investigator Interview: RTOG 3521
Combination Toripalimab and Chemotherapy in Recurrent Metastatic Nasopharyngeal Cancer
About RTOG Foundation
The RTOG Foundation is a nonprofit organization dedicated to improving outcomes for cancer patients through the conduct of practice changing clinical trials. RTOG collaborates with partners from industry and federally funded programs to support its research.
Partners
There are several ways you can participate in RTOG Foundation as either a member site, an industry collaborator, or by enrolling in one of our studies.
Participate in RTOG Research
To participate as an RTOG study investigator, your organization must be part of the RTOG Foundation network. Patients who wish to participate in a study must be under the care of an RTOG participating investigator. For additional information, email info@rtog.org or call 1-215-574-3173.